Dr. Isabel McFarlane, MD

Dr. McFarlane practices at University Hospital at Downstate in Brooklyn, New York, part of State University of New York.

Dr. McFarlane's NPI, 1548653512, was assigned on March 13, 2015. Dr. McFarlane holds New York license 278680.

Dr. McFarlane's primary practice is University Hospital at Downstate, at 445 Lenox Road, Brooklyn, NY 11203 in Kings County. The practice phone is (718) 270-1000.

Dr. McFarlane's primary practice is University Hospital at Downstate in Brooklyn, New York, part of State University of New York. The medical group on file is SUNY Downstate Health Sciences University.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McFarlane practices. Vendor and product names are available with a free account.

Internal medicine is Dr. McFarlane's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. McFarlane is licensed in New York.

CMS data shows 116 Medicare services from Dr. McFarlane across 2 procedure codes in 2024, for 36 Medicare patients. Medicare paid $10,319 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 36 Medicare patients who saw Dr. McFarlane in 2024. The largest group is 65 to 74, with 12 patients. 75% of them have diabetes, and 75% have high blood pressure. Their average risk score is 4.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McFarlane's median patient age at 67, with 49% women.

In 2024, Dr. McFarlane wrote 54 Medicare Part D claims for 18 patients. 87% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $5,119 in total drug cost.

Dr. McFarlane accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 20 papers to Dr. McFarlane, published from 2017 to 2024. 2022 was the busiest year, with 6. The most frequent topics are Arthritis, Rheumatoid and Heart Failure. Dr. McFarlane has published most often in Cureus. Dr. McFarlane's most frequent co-authors are Joshy Thomas Pathiparampil, MD, Navid Salahi, MD and Manjeet Singh Bhamra, MD.

CMS Open Payments shows 14 general payments to Dr. McFarlane from 9 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 98% of the total. Amarin Pharma Inc. paid the most, $130.